Dunxin Financial Holdings Announces Notification of NYSE American Continued Listing Deficiency
Dunxin Financial Holdings Limited (NYSE American: DXF) received a deficiency letter from NYSE American on March 6, 2023, due to low trading prices of its ADSs, which violates listing standards. The company must demonstrate sustained price improvement or consider a reverse stock split by September 6, 2023. While the letter does not lead to immediate delisting or impact business operations, Dunxin is actively developing plans to regain compliance within the cure period. The company has suspended loan offerings since 2020 and is exploring Metaverse-related technologies.
- Company is actively engaged in discussions with NYSE American to regain compliance.
- No immediate delisting or impact on business operations.
- Received a deficiency letter for non-compliance with continued listing standards.
- Low trading prices of ADSs have persisted for a substantial period.
- Suspended loan offerings since 2020.
The Letter stated that because the Company's ADSs had been trading for a low price per share for a substantial period of time, the Company was not in compliance with Section 1003(f)(v) of the Company Guide. The NYSE American staff determined that the Company's continued listing is predicated on it demonstrating sustained price improvement within a reasonable period of time or effecting a reverse stock split of its securities, which the staff determined to be until
The Letter has no immediate effect on the listing or trading of the Company's common stock and the ADSs will continue to trade on the NYSE American under the symbol "DXF". Additionally, the Letter does not result in the immediate delisting of the Company's common stock from the NYSE American. The Company's receipt of the Letter does not affect the Company's business, operations or reporting requirements with the
About
Dunxin is a licensed microfinance lender serving individuals and SMEs in
Safe Harbor Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of market in
View original content:https://www.prnewswire.com/news-releases/dunxin-financial-holdings-announces-notification-of-nyse-american-continued-listing-deficiency-301768702.html
SOURCE
FAQ
What did the deficiency letter for DXF entail?
What actions does Dunxin intend to take regarding the deficiency letter?
Is Dunxin Financial Holdings currently at risk of immediate delisting?
How long has Dunxin suspended loan offerings?